Abeona Therapeutics Inc.
ABEO
$6.54
-$0.20-2.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.03M | -9.29M | -30.27M | 7.41M | -31.58M |
| Total Depreciation and Amortization | 815.00K | 776.00K | 722.00K | 685.00K | 724.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.77M | -4.21M | 17.49M | -23.22M | 19.13M |
| Change in Net Operating Assets | -3.42M | -3.84M | -178.00K | 2.45M | -2.82M |
| Cash from Operations | -18.40M | -16.56M | -12.23M | -12.68M | -14.54M |
| Capital Expenditure | -1.40M | -606.00K | -404.00K | -711.00K | -725.00K |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 18.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.61M | 19.48M | -5.76M | -43.44M | -7.09M |
| Cash from Investing | 4.21M | 18.88M | -6.17M | -44.13M | -7.82M |
| Total Debt Issued | -- | 0.00 | 0.00 | 0.00 | 20.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.80M | 5.51M | 0.00 | 73.70M | 6.42M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -31.00K | -199.00K | -299.00K | -14.00K | -977.00K |
| Cash from Financing | 6.77M | 5.31M | -299.00K | 73.68M | 25.44M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.42M | 7.63M | -18.70M | 16.87M | 3.09M |